Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutrition in Short Bowel Syndrome (SBS) at Digestive Disease Week® 2026 Ironwood Pharmaceuticals, Inc. a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and…
Uqora® Launches Cutting-Edge Urinary Health Products at Target Uqora, the rapidly growing and cutting-edge urinary tract health brand, today announces its retail expansion into Target stores and online at Target.com. Through a growing omnichannel footprint, Uqora is increasing the accessibility of…
Artera Secures CE Marking for Its AI Prostate and Breast Cancer Assays, Unlocking Global Expansion Artera, a developer of multimodal AI-based prognostic and predictive cancer tests, announced today that it was granted CE marking under the European Union In Vitro Diagnostic…
Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments Compass Pathways plc a biotechnology company dedicated to accelerating patient access to evidence-based innovation, welcomes the White House Executive Order on accelerating medical treatments for…
SAGA Diagnostics to Present New Pathlight™ MRD Data for Ovarian and Metastatic Breast Cancer at AACR 2026 SAGA Diagnostics, a pioneer in blood-based cancer detection and precision medicine redefining the standard for early molecular residual disease (MRD) detection, announced that the…
Onchilles Pharma Presents at AACR 2026 New Preclinical Data from the Systemically Delivered NEU-002 Program, Supporting Advancement Toward Development Candidate Selection Onchilles Pharma, a private biotech company advancing therapeutics targeting the ELANE pathway, announced new preclinical data from its NEU-002…
Foundation Medicine to Strengthen Monitoring Portfolio with SAGA Diagnostics’ Tumor-Informed Molecular Residual Disease (MRD) Platform Foundation Medicine, Inc., a global, patient-focused precision medicine company and an independent affiliate of Roche, announced it is set to expand its monitoring portfolio with…
Delve Detect Enables Neurologists to Treat CNS Infections When Conventional Testing Fails Delve Bio, a UCSF spin-out and pioneer in metagenomic next-generation sequencing (mNGS) for infectious diseases, announced data underscoring the clinical impact of mNGS using Delve Detect to identify pathogens and…
Forlong Biotechnology Announced CMC Readiness to Initiate GMP Batch Production to Support Upcoming Pivotal Clinical Trial for FL115 (IL-15 Superagonist) in Nonmuscle Invasive Bladder Cancer (NMIBC) Forlong Biotechnology, a clinical-stage biotech company focusing on developing transformative cytokine therapies for patients…
NorthStar Secures FDA Acceptance of Drug Master File for No-Carrier-Added Actinium-225 NorthStar Medical Radioisotopes, LLC a leading radiopharmaceutical company, today announced that it received notice of the U.S. Food & Drug Administration’s (FDA) acceptance of its Type II Drug Master…
AMGTA Releases Independent Report on Additive Manufacturing’s Role in Resource-Efficient Manufacturing Systems Following its 2026 Annual Member Summit, AMGTA released Additive Manufacturing in Resource-Efficient Manufacturing Systems, an independent report establishing how additive manufacturing should be evaluated, communicated, and deployed across part,…
Organon’s VTAMA® (tapinarof) cream, 1%, Granted Strong Recommendation in the 2026 American Academy of Dermatology Guidelines for Pediatric Atopic Dermatitis Organon a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, today announced…